Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Fall Home Improvement
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
2024 Auction
2024 Readersâ Choice Awards
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Bio-Rad Laboratories
(NY:
BIO
)
275.60
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Apr 25, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Bio-Rad Laboratories
< Previous
1
2
Next >
Bio-Rad to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024
April 18, 2024
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad’s Chief Operating Officer Andrew Last to Retire
April 10, 2024
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad Appoints Roop K. Lakkaraju Executive Vice President, Chief Financial Officer
March 20, 2024
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad to Participate in Fireside Chat During Citi's 2024 Unplugged Medtech and Life Sciences Access Day
February 22, 2024
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad Laboratories Inc. (NYSE: BIO) is a Leading Gainer in Wednesday Morning Trading
September 13, 2023
Via
Investor Brand Network
Bio-Rad Reports Fourth-Quarter and Full-Year 2023 Financial Results
February 15, 2024
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, February 15, 2024
January 24, 2024
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad’s Management to Host Investor Meetings at J.P. Morgan’s 42nd Annual Healthcare Conference
January 02, 2024
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad Reports Third-Quarter 2023 Financial Results
October 26, 2023
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad to Report Third Quarter 2023 Financial Results on Thursday, October 26, 2023
October 05, 2023
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad to Participate in Fireside Chat During Wells Fargo’s 2023 Healthcare Conference
August 28, 2023
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad Reports Second-Quarter 2023 Financial Results
August 03, 2023
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad and QIAGEN Announce Patent Settlement and Cross-Licensing Agreement
July 26, 2023
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad Announces New Share Repurchase Program
July 20, 2023
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad to Report Second Quarter 2023 Financial Results on Thursday, August 3, 2023
July 10, 2023
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad Publishes Corporate Sustainability Report for 2022
July 10, 2023
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad to Present Company Overview at Jefferies Healthcare Conference
June 01, 2023
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad to Participate in Fireside Chat During 2023 RBC Capital Markets Global Healthcare Conference
May 08, 2023
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad Reports First-Quarter 2023 Financial Results
May 04, 2023
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad to Report First Quarter 2023 Financial Results on Thursday, May 4, 2023
April 12, 2023
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad to Participate in Citi’s 2023 Healthcare Services, MedTech, Tools & HCIT Conference
February 17, 2023
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad Reports Fourth-Quarter and Full-Year 2022 Financial Results
February 16, 2023
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Cytek® Biosciences Partners with Bio-Rad to Expand Reagent Portfolios
February 07, 2023
New Agreement Enhances High-Parameter Panels on Cytek Cell Analysis Systems
From
Cytek Biosciences, Inc.
Via
GlobeNewswire
Bio-Rad to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, February 16, 2023
January 06, 2023
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad to Present Company Overview at J.P. Morgan 41st Annual Healthcare Conference
January 04, 2023
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad To Participate in Fireside Chat During Credit Suisse’s 31st Annual Healthcare Conference
October 31, 2022
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad Reports Third-Quarter 2022 Financial Results
October 27, 2022
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad to Report Third Quarter 2022 Financial Results on Thursday, October 27, 2022
October 17, 2022
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad Acquires Curiosity Diagnostics
August 03, 2022
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad Reports Second-Quarter 2022 Financial Results
July 28, 2022
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.